Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Keeps you up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
![Essential](https://www.g2intelligence.com/wp-content/uploads/2023/11/Essential.png)
![62934_G2_Subscription Website Images_JL V1](https://www.g2intelligence.com/wp-content/uploads/2023/11/62934_G2_Subscription-Website-Images_JL-V1.png)
![Special-Report](https://www.g2intelligence.com/wp-content/uploads/2023/11/Special-Report.png)
![62934_G2_Subscription Website Images_JL V12](https://www.g2intelligence.com/wp-content/uploads/2023/11/62934_G2_Subscription-Website-Images_JL-V12.png)
![Special-Analysis](https://www.g2intelligence.com/wp-content/uploads/2023/11/Special-Analysis.png)
![Elite](https://www.g2intelligence.com/wp-content/uploads/2023/11/Elite.png)
Additional Business Intelligence Offerings
Lab Industry Advisor Subscriptions Include
![paper_magnifing_glass_512](https://www.g2intelligence.com/wp-content/uploads/2023/11/paper_magnifing_glass_512.png)
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
FDA Issues First Ever Approval for a COVID-19 Breathalyzer
The FDA announced that, for the first time, it has granted Emergency Use Authorization for a COVID-19 breathalyzer test.
Labs in Court Weekly Roundup
All of last week’s key cases announced by the DOJ involving the health care industry related to companies settling false claims-related allegations.
Annual Screening for Breast Cancer Survivors Is Declining
Recently published research shows that annual mammography rates for survivors aged 40 to 64 have been dropping since 2009.
False Billing of Urine Drug Tests Costs NC Lab $11.6 Million
Radeas LLC is also required to enter into a five-year corporate integrity agreement as part of the settlement.
Mastermind or Swindled Shareholder? The Balwani Trial Continues
Prosecution insists that Holmes and Balwani were “partners in everything, including their crimes.”
FY 2021 Medicaid Fraud Report Shows Increase in Recoveries
OIG report on Medicaid Fraud Control Unit enforcement activity in fiscal year FY 2021 shows recoveries are up, despite fewer cases.
Recent CE-IVD Marks Mostly Related to Cancer Testing
In CE-IVD-related announcements made over last week, the majority involved the cancer testing market.
Whatever Happened to the Health Care Blank-Check Company?
After peaking in the first quarter of 2021, with 42 SPACs raising a total of $11 billion, the blank-check company craze has fallen off significantly.
HHS Signals that the End of the PHE Is Near
Last week, CMS announced that it was eliminating certain waivers and regulatory flexibility it provided when the COVID-19 pandemic began.
Labs in Court Weekly Roundup
While labs weren’t featured in this week’s enforcement actions, clinics and hospitals, and individuals involved in these organizations, were in hot water, mainly for False Claims Act violations. April 6: The former owner of a cash-only pain management clinic in...